Document Detail


Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients.
MedLine Citation:
PMID:  12323156     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The aim of the present study was to investigate whether use of specific antibiotic drugs decreases the risk of coronary heart disease in diabetes mellitus type 2 patients. METHODS AND RESULTS: Data were obtained from the PHARMO Record Linkage System comprising pharmacy records and hospitalizations for all 450,000 residents of eight Dutch cities. In a nested case-control study among diabetes mellitus type 2 patients, 244 cases with a first hospitalization for coronary heart disease and 686 controls without coronary heart disease matched on age, sex, calendar time, and registration date in PHARMO RLS were selected. Use of antibiotic drugs among cases and controls was determined over 3 years prior to the event. Use of fluorquinolones for more than 14 days compared to no use of fluorquinolones was associated with a lower risk of coronary heart diseases (OR(adj)=0.30 (95%CI: 0.12-0.75)). No association between tetracycline, macrolide and lincosamide treatment, or other antibiotic drugs (penicillins, cephalosporines, sulphonamides and trimethoprim), and the risk of coronary heart disease was found. CONCLUSION: Our results suggest that treatment with fluorquinolones in doses commonly prescribed in routine clinical practice is associated with a reduction in the risk of coronary heart diseases among diabetes mellitus type 2 patients.
Authors:
J A Erkens; O H Klungel; R M C Herings; R P Stolk; J A Spoelstra; D E Grobbee; H G M Leufkens
Related Documents :
2468976 - Risk factors in hypertension.
10353066 - Decreasing mortality from acute myocardial infarction: effect of incidence and prognosis.
2923116 - Trends in the incidence of myocardial infarction in western australia between 1971 and ...
11583876 - Role of kozak sequence polymorphism of platelet glycoprotein ibalpha as a risk factor f...
7845826 - Diagnosis of atrial arrhythmias using the holter function of a new ddd pacemaker.
15136066 - A serum amyloid a and ldl complex as a new prognostic marker in stable coronary artery ...
Publication Detail:
Type:  Comment; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  23     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-09-26     Completed Date:  2002-12-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1575-9     Citation Subset:  IM    
Copyright Information:
Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Affiliation:
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Case-Control Studies
Control Groups
Coronary Disease / prevention & control*
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Angiopathies / prevention & control*
Female
Fluoroquinolones / therapeutic use*
Humans
Male
Medical Record Linkage
Risk
Chemical
Reg. No./Substance:
0/Fluoroquinolones
Comments/Corrections
Comment On:
Eur Heart J. 2002 Oct;23(20):1557-9   [PMID:  12323150 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A study of the use of Overhauser enhancement to assist with needle and catheter placement during int...
Next Document:  Smoking and plasma homocysteine.